This is an Insight article, written by a selected contributor as part of GCR’s co-published content. Read more on Insight
Ukraine’s competition law is rapidly transforming as the Antimonopoly Committee intensifies enforcement in key sectors like pharmaceuticals, while navigating new foreign direct investment screening rules and partial state aid controls. High-profile merger reviews, landmark leniency cases and stringent actions against misleading supplement claims reveal a regulatory landscape striving to balance wartime economic pressures with alignment to EU standards. These developments underscore Ukraine’s commitment to building a modern, resilient competition framework despite ongoing conflict and institutional challenges.
To read more
Subscribe to Global Competition Review
Register for limited access
Register for free to unlock full access to our Insight content, including Guides, Reviews and Hubs. Plus, get our newsletter straight to your inbox.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below